Guidelines for the management of cognitive and behavioral problems in dementia

Journal of the American Board of Family Medicine : JABFM
Carl H Sadowsky, James E Galvin

Abstract

Family physicians play a crucial role in the management and ongoing care of patients with Alzheimer disease (AD). This article reviews the effects of nonpharmacologic and pharmacologic interventions on the functional abilities and behavior of patients with dementia and how these can be implemented into clinical practice. Nonpharmacologic interventions are recommended as the initial strategy for managing problematic behaviors. Strategies for improving behavior include ensuring that the patient's environment is safe, calm, and predictable; removing environmental stressors; and identifying and avoiding situations that agitate or frighten the patient. Simple interventions include redirecting and refocusing the patient, increasing social interaction, establishing regular sleep habits, eliminating sources of conflict and frustration, and establishing rewards for successes. The effectiveness of long-term behavioral management is largely dependent on the caregiver; as such, it is important to assess the role and needs of the caregiver. Because currently available therapies cannot reverse the pathologic processes of AD, the primary objective of pharmacotherapy is to preserve cognitive and functional ability, minimize behavioral disturba...Continue Reading

Citations

Aug 13, 2013·Biochemical Pharmacology·Lilia ZurkovskyPaul A Newhouse
Aug 13, 2013·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·S Noël, G Noël
Jan 26, 2013·International Psychogeriatrics·Perla WernerEliezer Kitai
Oct 2, 2013·Journal of Aging Research·Philip A DefinaJonathan Fellus
Oct 3, 2013·International Journal of Nursing Studies·Ching-Tzu YangYea-Ing Lotus Shyu
Sep 21, 2013·Health Care Management Science·Manaf ZargoushRaya Kheirbek
Jul 20, 2014·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·B GuarnieriS Sorbi
Dec 18, 2014·Issues in Mental Health Nursing·Marianne Thorsen Gonzalez, Marit Kirkevold
Apr 25, 2013·International Review of Psychiatry·Marla B Bruns, Keith A Josephs
Jan 12, 2016·Current Neurology and Neuroscience Reports·Cynthia BartonBruce Miller
Oct 2, 2012·Metabolism: Clinical and Experimental·Theodore B Vanitallie
Oct 28, 2014·Journal of Gerontological Nursing·Ann M MitchellKirsti Hetager Stark
Jul 31, 2013·Journal of the American Geriatrics Society·Saskia N SivananthanKimberlyn M McGrail
Mar 31, 2015·Annals of Clinical and Translational Neurology·Jeffrey L CummingsDrew M Velting
May 10, 2015·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Saskia N SivananthanKimberlyn M McGrail
May 28, 2016·The Nursing Clinics of North America·Carolyn Seeganna, Deborah Antai-Otong
Feb 24, 2015·The Medical Clinics of North America·Kerry L Hildreth, Skotti Church
Aug 26, 2014·Frontiers in Behavioral Neuroscience·Natalia KulesskayaVootele Voikar
Oct 10, 2014·Drug and Therapeutics Bulletin
Sep 21, 2016·Computational and Mathematical Methods in Medicine·René F NavarroJesús Favela
Dec 7, 2016·Methods of Information in Medicine·Darién MirandaBert Arnrich
Jan 27, 2017·International Psychogeriatrics·Maria R Santa CruzSuzanne Holroyd
Dec 16, 2017·Gerontology & Geriatric Medicine·R C HamdyK Whalen
Oct 21, 2017·Gerontology & Geriatric Medicine·R C HamdyK Whalen
Sep 15, 2017·Gerontology & Geriatric Medicine·R C HamdyK Whalen
Mar 15, 2015·International Psychogeriatrics·Jesus GonzalezJuan C Meléndez
Apr 30, 2013·Expert Review of Neurotherapeutics·Lucy NelsonPaul Gard
Feb 21, 2018·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·O A Kicherova, L I Reikhert
Jan 11, 2020·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Greg CarneyColin R Dormuth
May 11, 2018·Aging & Mental Health·Nattawut Leelakanok, Ronilda R D'Cunha
May 18, 2019·Drugs in R&D·Stephanie V PhanSusan C Fagan
Jul 23, 2016·Journal of Medical Systems·Darien MirandaNetzahualcoyotl Cruz
Mar 22, 2018·Annals of Rehabilitation Medicine·Sungchul HuhHyun-Yoon Ko
Jan 20, 2018·Gerontology & Geriatric Medicine·R C HamdyK Whalen
Jan 1, 2015·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·E E Vasenina, O S Levin
Jun 15, 2018·Gerontology & Geriatric Medicine·R C HamdyJ Culp

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.